(HealthDay)—Neuronal heparan sulfates (HSs) modulate brain amyloid-β (Aβ) clearance and aggregation in a mouse model of Alzheimer’s disease (AD), according to an experimental study published in the March 30 issue of Science Translational Medicine.
from Dementia Big http://ift.tt/1RNksid
via Stopping Dementia
from WordPress http://ift.tt/1UHkHzd
via alcoholic dementia
http://ift.tt/1MGy0gm
No comments:
Post a Comment